pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    Bicillin L A
    Bicillin L A (penicillin G benzathine)
    Upper Respiratory Tract Infections by Streptococcus pyogenes$PFE PFIZER INC
  • Phase 1
    CB-06036
    Hepatitis B$GSK GSK plc
  • Phase 2
    CDI-988
    Norovirus Infections$COCP Cocrystal Pharma, Inc.
← prev
page 7 of 24
next →
Pain89
Neurology1
Phase 1
CK-0802
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
Cellenkos Inc
  • Phase 2
    CMTX-101
    Pseudomonas aeruginosa Infections Clarametyx Biosciences Inc
  • Phase 2
    COVID-19 (S Protein)
    Coronavirus Disease 2019 (COVID-19)$VXRT Vaxart, Inc.
  • pre_registration
    COVID-19 (omicron JN.1) vaccine
    Covid-19 (Omicron JN.1) Vaccine
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • Phase 3
    COVID/Influenza Combination Vaccine
    Seasonal Influenza$NVAX NOVAVAX INC
  • Phase 2
    CRS-3123
    Clostridioides difficile Infections (Clostridium difficil… Crestone Inc
  • Preclinical
    CSA-CFI
    Pseudomonas aeruginosa Infections Kinnear Pharmaceuticals LLC
  • Phase 1
    CSL-404
    Pandemic Influenza$CSLLY CSL LTD
  • Preclinical
    CTX-002
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Ceria Therapeutics Inc
  • Preclinical
    CTX-187
    Gram-Negative Bacterial Infections Centauri Therapeutics Ltd
  • Preclinical
    CVX-20733
    Coronavirus Disease 2019 (COVID-19) Covirix Medical Pty Ltd
  • Preclinical
    CVX-20799
    Coronavirus Disease 2019 (COVID-19) Covirix Medical Pty Ltd
  • Phase 2
    CampETEC
    Campylobacter Infections$IMRN Immuron Ltd
  • Phase 1
    Campylobacter jejuni [strain CPS81-176] vaccine
    Campylobacter Infections US Army Medical Research & Materiel Command
  • Phase 1
    CodaVax-RSV
    Respiratory Syncytial Virus (RSV) Infections Codagenix Inc
  • Marketed
    Comirnaty KP.2
    Omicron KP.2-adapted monovalent COVID-19 vaccine
    Coronavirus Disease 2019 (COVID-19) BioNTech US Inc
  • Marketed
    Comirnaty LP.8.1
    Comirnaty LP.8.1
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Phase 3
    Coronavirus Disease 2019 (COVID-19) + influenza vaccine
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Marketed
    Coronavirus Disease 2019 (COVID-19) KP.2 vaccine
    Spikevax KP.2
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • Marketed
    Coronavirus Disease 2019 (COVID-19) vaccine 1
    Covid-19 Vaccine (mivalsecovatein [INN])
    Coronavirus Disease 2019 (COVID-19)$NVAX NOVAVAX INC
  • Preclinical
    Coronavirus Disease 2019 (COVID-19) vaccines
    Coronavirus Disease 2019 (COVID-19) University of Florida
  • Marketed
    Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
    Spikevax Omicron XBB.1.5
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • Marketed
    Cyfendus
    Cyfendus
    Anthrax$EBS Emergent BioSolutions Inc.
  • Preclinical
    Cyto-111
    Botulism CytoDel Inc
  • Phase 1
    D-121
    Visceral Leishmaniasis (Kala-Azar) Oblita Therapeutics BVBA
  • Phase 3
    DAS-181
    Human Parainfluenza Virus 3 Infections Ansun Biopharma Inc
  • Preclinical
    DCOY-102
    Coronavirus Disease 2019 (COVID-19)$DCOY Decoy Therapeutics Inc.